Opportunities in the Global Refractory Follicular Lymphoma Diagnostics Market include the growing need for MRD monitoring and liquid biopsies, driven by the rise in hematologic malignancies. The surge ...

The Global Mantle Cell Lymphoma Market offers significant growth potential driven by an aging population increasing cancer ...

Patients with Waldenström Non-Hodgkin lymphoma in the U.S. achieved durable complete responses of up to 15 months using a chemotherapy-free CD19 CAR-NK (chimeric antigen receptor natural killer) cell ...

The Food and Drug Administration (FDA) has approved Breyanzi ® (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) ...

Since then Ross Esparza has “perplexed the medical community with unexplained lesions, masses, blood work and biopsies,” said ...

Death rates from colorectal cancer, however, have continued to rise in younger adults, becoming the leading cause of cancer ...

Michael Wang, MD, highlights ASH 2025 data showing how continual innovation across targeted agents, cellular and immune ...

Incyte (INCY) analysis: strong risk-adjusted returns, 20% YoY Q3 2025 revenue growth, diversification beyond Jakafi, and fair ...

These stocks offer impressive long-term upside with downside protection.

year survival rates averaged across all cancers have never been higher, with 7-in-10 cancer patients living past 5 years post-diagnosis.

Michael Wang, MD, highlights standout translational studies from ASH 2025 that advance understanding of prognosis and drug ...

EastEnders fans are in for a treat when Mark Fowler's nephew, Mark Junior, returns to the soap this month, 36 years after the ...